Kaufen Verkaufen. About the Onconova Therapeutics, Inc. stock forecast. 0.300 Based on our forecasts, a long-term increase is expected, Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM . Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. VALOR: 10019113 / ISIN: CH0100191136. This is huge news and why RLFTF stock is a bargain at a $1.54 billion market cap. Sign-up to receive the latest news and ratings for RLFTF and its competitors with MarketBeat's FREE daily newsletter. Compare Top Brokerages Here. +144.23% Rooms Shows Rankings Earnings Calendar Shop. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Vote “Underperform” if you believe RLFTF will underperform the S&P 500 over the long term. View our full suite of financial calendars and market data tables, all for free. Best Relief Therapeutics Holding AG forecast, Relief Therapeutics Holding AG 0.32 0.01 (2.55%) Watch . As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. News zur RELIEF THERAPEUTICS AKTIE und aktueller Realtime-Aktienkurs Relief Therapeutics erhöht das Kapital um 125 Mio Aktien If you are looking for stocks with good return, Relief Therapeutics Holding AG can be a profitable investment option. RELIEF THERAPEUTICS Holding Ltd. Straße: Avenue de Sécheron 15: PLZ: 1202: Stadt: Geneve: Land: Schweiz: Telefon +41-44-7235959: Fax +41-41-61109-34: Webseite: www.relieftherapeutics.com: E … 31.1%. Is Relief Therapeutics Holding AG a profitable investment? Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Learn about financial terms, types of investments, trading strategies and more. At current levels, Relief Therapeutics is an absolute steal. And, here we go again, as a supply crisis could fuel a new lithium craze. There is not enough analysis data for Relief Therapeutics. Relief Therapeutics does not currently pay a dividend. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. The entity stock is not elastic to its hype. Get short term trading ideas from the MarketBeat Idea Engine. Stock analysis for Relief Therapeutics Holding AG (RLF:SIX Swiss Ex) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 0.00 (0.00 %) (As of 03/3/2021 12:00 AM ET) Today's Range. Your estimate tool on this stock looks incorrect. Real-time trade and investing ideas on Relief Therapeutics Holding AG RLFTF from the largest community of traders and investors. Sign Up. How is Relief Therapeutics Holding forecast to perform in the next 1 to 3 years based on estimates from 1 analyst? What To Make Of Poshmark’s First Earnings Report. Is it Too Late to Buy Burlington Stores Stock? Learn more. One share of RLFTF stock can currently be purchased for approximately $0.30. … News + Analysen. 0.733 USD in This time it won’t be different! one why is the price of CAKE keep going up, when restaurants are going out of business everywhere. Will RLFTF price go up? I’m very excited about the possibilities for this stock. Log In and Add. Based on an average daily trading volume, of 24,458,300 shares, the days-to-cover ratio is presently 0.3 days. Relief Therapeutics does not have a long track record of dividend growth. In 2023, TXMD's EPS is forecast to hit $0.13 (min: $0.04, max: $0.22). Relief Therapeutics said its partner NeuroRx and the Quantum Leap Healthcare Collaborative signed an agreement to include Zyesami in the I-SPY COVID-19 clinical trial, a … Not within a year. Relief Therapeutics has received 66.67% “underperform” votes from our community. Relief devised a swift plan of action to respond to one of the largest healthcare disasters our time by rapidly advancing RLF-100™ towards approval in COVID-19-induced lung injury. We said RLFTF was undervalued before the recent drop. They missed their target on earnings by a... My1972vert — Relief Therapeutics Holding AG projections, Policy, Relief Therapeutics Holding AG Stock Price Forecast for 2021, Relief Therapeutics Holding AG Stock Price Forecast for 2022, Relief Therapeutics Holding AG Stock Price Forecast for 2023, Relief Therapeutics Holding AG Stock Price Forecast for 2024, Relief Therapeutics Holding AG Stock Price Forecast for 2025, Relief Therapeutics Holding AG Stock Price Forecast for 2026. RLFTF prediction, Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease . To see all exchange delays and terms of use please see disclaimer. Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief in serious diseases with high unmet medical need. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications. Unprepared investors always get killed in megatrends. 0.300 USD to Earnings and Revenue Growth Forecasts . Shares of RLFTF can be purchased through any online brokerage account. S&P 500 0.00%. RELIEF THERAPEUTICS is at this time traded for 0.32on Switzerland Exchange of Switzerland. Learn everything you need to know about successful options trading with this three-part video course. Pain Relief Therapeutics Market Significant Growth by Pfizer, Abbott, BioDelivery Sciences International, Heron Therapeutics, Amgen, Novartis. The company can be reached via phone at 41 44 723 59 59. As of February 26th, there was short interest totaling 7,792,100 shares, an increase of 141.2% from the February 11th total of 3,230,400 shares. View all of RLFTF's competitors. Relief Therapeutics Holding AG OTC Updated Mar 10, 2021 5:37 PM. When will RLFTF stock price go down? Its RLF-100 is also used for pulmonary sarcoidosis. A high-level overview of Relief Therapeutics Holding AG (RLFTF) stock. Term Box: Based on an average daily trading volume, of 42,294,600 … The official website for Relief Therapeutics is www.relieftherapeutics.com. in one year. RLFTF expected stock price. Pain Relief Therapeutics Market By Therapeutics (Non-steroidal Anti-inflammatory Drugs, Anesthetics, Anticonvulsant, Antimigrane Agents, Antidepressants), By Indication (Arthritic Pain, Cancer Pain, Neuropathic Pain, Chronic back Pain, Post-operative Pain), By Distribution channel (Hospital Pharmacy, Drug Stores, Online Pharmacy), Industry Analysis, Trends, and Forecast 2018 – 2024 Sign in, Not a member? The RLFTF ("RLFTF" ) In 2023, OTLK's EPS is forecast to hit $1.09 (min: $1.09, max: $1.09). On average, analysts forecast that TXMD's EPS will be $-0.36 for 2021, with the lowest EPS forecast at $-0.45, and the highest EPS forecast at $-0.21. Looking for new stock ideas? You can opt out at any time. Get RELIEF THERAPEUTICS Holding SA (0QKQ-GB:London Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. 2.328 USD . Nachrichten zur Aktie Relief Therapeutics | A1H80W | RLFTF | CH0100191136 DAX : 14.540 +0,7% ESt50 : 3.820 +0,9% TDax : 3.306 -0,1% Dow : 32.297 +1,5% Nas : 13.069 -0,0% Bitcoin : 47.216 … Yes. The average elasticity to hype of competition is 0.0. View real-time stock prices and stock quotes for a full financial overview. Relief Therapeutics Holding AG quote is equal to 0.329 USD at 2021-03-10. from The company is also involved in the clinical development of RLF-100 that is in planning stage for other indications in acute and chronic lung diseases. Relief Therapeutics Holding AG stock forecast, Use Get daily stock ideas top-performing Wall Street analysts. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. zugeh. Will Relief Therapeutics Holding AG stock price fall? On average, analysts forecast that OTLK's EPS will be $-0.21 for 2022, with the lowest EPS forecast at $-0.21, and the highest EPS forecast at $-0.21. Relief Therapeutics Holding AG Stock Price Forecast, "RLFTF" Predictons for2023 Is It Time To Get Crazy With El Pollo Loco Stock? STOCK / COMPANY • Relief Therapeutics is a small company in Switzerland that holds the patent on RLF-100. See above. Fundamental. Relief Therapeutics saw a increase in short interest in February. © American Consumer News, LLC dba MarketBeat® 2010-2021. Relief Therapeutics Holding AG technical analysis, On average, analysts forecast that OTLK's EPS will be $-0.49 for 2021, with the lowest EPS forecast at $-0.49, and the highest EPS forecast at $-0.49. According to our analysis, this will not happen. Want to see which stocks are moving? Wall Street analysts have given Relief Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Relief Therapeutics Holding AG analyst report, RELIEF THERAPEUTICS Realtimekurs - hier erhalten Sie kostenlose Pushkurse und Realtimekurse inklusive Realtimechart für die RELIEF THERAPEUTICS Aktie Relief Therapeutics Holding AG (RLFTF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Identify stocks that meet your criteria using seven unique stock screeners. Cancel. RLFTF forecast, Forecasted annual revenue growth. View Relief Therapeutics' Short Interest. See what's happening in the market right now with MarketBeat's real-time news feed. Stock analysis for Relief Therapeutics Holding AG (RLFTF:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Fundamental company data provided by Zacks Investment Research. For all these reasons, we believe RLFTF is a must-own. NASDAQ 0.00%. future stock price will be • In August 2020, Relief up-listed from “OTC Pink” to the higher-tier “OTCQB” to allow a broader range of investors. Wertpapiere. All indications are that RLF-100 is effective and we are now waiting for a EUA and top-line data in January. 21 … Help us improve our free forecast service with share! View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Relief Therapeutics has received 1 “outperform” votes. Will RLFTF stock price rise? Is RLFTF stock price going to drop? Kurse + Charts + Realtime. Will RLFTF price drop? Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Get RELIEF THERAPEUTICS Holding SA (RLFTF:OTCQB) real-time stock quotes, news, price and financial information from CNBC. Your current $100 investment may be up to $776.03 in 2026. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. As of February 12th, there was short interest totaling 3,230,400 shares, an increase of 27.1% from the January 28th total of 2,541,200 shares. The company focuses on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Question Box: Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. MarketBeat just released five new trading ideas, but Relief Therapeutics wasn't one of them. Stijnen as Chief Commercial Officer, Receive Analysts' Upgrades and Downgrades Daily. doronhaen_7519 — View which stocks are hot on social media with MarketBeat's trending stocks report. Relief Therapeutics saw a increase in short interest in the month of February. Find the latest RELIEF THERAPEUTICS N (RLF.SW) stock quote, history, news and other vital information to help you with your stock trading and investing. Note: due to the specific nature of Relief Therapeutics Holding AG stock, the prediction can be significantly excessive / unrealistic! Trending now. Through its multimodal mechanism of action, RLF-100™ may uniquely target the pathways attacked by the SARS-CoV-2 virus (COVID-19), preventing acute lung injury (ALI). Find the latest REVIVE THERAPEUTICS LTD (RVVTF) stock quote, history, news and other vital information to help you with your stock trading and investing. RLFTF stock is on the move today after Relief Therapeutics gave a positive update on its Covid-19 treatment. Learn more. USD today. 12, 2021, 07:45 PM Relief Therapeutics Holding AG market prognosis, expected to be around +676.03%. Receive a free world-class investing education from MarketBeat. MarketBeat's community ratings are surveys of what our community members think about Relief Therapeutics and other stocks. RLF-100 is being investigated in two placebo-controlled U.S. phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. • Relief is traded over the counter (OTC) on the Swiss SIX exchange. $0.34. Historical How will Relief Therapeutics Holding AG stock price increase? Export data to Excel for your own analysis. Find the latest RELIEF THERAPEUTICS HOLDING AG (RLFTF) stock quote, history, news and other vital information to help you with your stock trading and investing. Aktion. RLFTF stock future price, 25 January 2021. This could be the hottest MJ ground-floor play around! Analyst Future Growth Forecasts. Sitting at .022 for the better part of a week and you have it moving to $6... Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Fujian Blue Hat Interactive Entertainment Technology Ltd (BHAT) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Leo Holdings Corp. Units each consisting of one Class A ordinary share and one-third of one redeemable warrant (LHC-U) Stock Forecast, Gamestop Corporation - Class A (GME) Stock Forecast, > Page 2: detailed data / stock price table <, Cheesecake Factory Stock Forecast, "CAKE" Share Price Prediction Charts, Enzolytics Stock Forecast, "ENZC" Share Price Prediction Charts, Asia Broadband Stock Forecast, "AABB" Share Price Prediction Charts, Environmental Waste International Stock Forecast, "EWS" Share Price Prediction Charts, Data Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. DOW 0.00%. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Relief Therapeutics Holding AG (RLFTF). When will RLFTF price fall? All rights reserved. If you are looking for stocks with good return, Relief Therapeutics Holding AG can be a profitable investment option. Relief Therapeutics trades on the OTCMKTS under the ticker symbol "RLFTF.". They missed their target on earnings by a... I’m very excited about the possibilities for this stock. (Add your “underperform” vote.). MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. RLFTF forecast tomorrow, We now have a timeline for Relief Therapeutics. (Add your “outperform” vote. ), Relief Therapeutics has received 2 “underperform” votes. goldmedalent1_4537 — * Our share forecasts and predictions are made by, Relief Therapeutics Holding AG Forecast. RLFTF | Complete RELIEF THERAPEUTICS Holding AG stock news by MarketWatch. $0.34. Unternehmen. Start Your Risk-Free Trial Subscription Here, Ferroglobe Will Get a Big Lift From Demand For Silcon Wafers, Blue Bird Stock is a Dual Tailwinds EV and Re-Opening Play, Nautilus Stock is a Pullback Buying Opportunity Here, The Launch of Truforma Should Send Zomedica to An All-Time High, Defi Markets Pause But New Highs Are In Sight. Some companies that are related to Relief Therapeutics include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), 17031 (MYM), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), ADiTx Therapeutics (ADTX), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF) and Almirall (LBTSF). RLFTF stock price predictions 2021, Please log in to your account or sign up in order to add this asset to your watchlist. This site is off balance? Relief Therapeutics Forum: Alle Diskussionen und aktuellen Beiträge aus dem Relief Therapeutics Forum auf ARIVA.DE, der Börsen-Community, in der Übersicht. Is Relief Therapeutics Holding AG price going up? Relief Therapeutics Holding AG quote is equal to 0.300 USD at 2021-03-12. You may vote once every thirty days. 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, Relief Therapeutics Holding AG: Relief Increases Issued Share Capital with Creation of Treasury Shares, Relief Increases Issued Share Capital with Creation of Treasury Shares, NeuroRx Announced that RLF-100(TM) has Demonstrated Ten-Day Accelerated Recovery from Respiratory Failure among Patients with Severe Covid-19 Treated with HFNO at 28 Day Interim Endpoint, Swiss-Based Biotech Pops On Covid-19 Related Results, Relief Therapeutics' RLF-100 can reduce hospital stay due to COVID-19, Relief Confirms Release of Preliminary Findings from Phase 2b/3 Trial of Intravenous RLF-100(TM) (aviptadil), NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™, Relief Therapeutics Holding AG: Relief Announces Resignation of Thomaz Burckhardt as Member of the Board of Directors, Relief Announces Resignation of Thomaz Burckhardt as Member of the Board of Directors, NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ in Reducing Hospital Stay Among Patients with Respiratory Failure due to Critical COVID-19, NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ (aviptadil) in Reducing Hospital Stay among Patients with Respiratory Failure due to Critical COVID-19, Relief Affirms Initiation of Phase 2/3 Trial of Inhaled RLF-100(TM) (Aviptadil; ZYESAMI(TM)) in Severe COVID-19 Patients, Relief Therapeutics and Acer ink option agreement for development of ACER-001, Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease, Relief Therapeutics Holding AG: Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM, Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM, Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil, NeuroRx, Relief, Quantum Leap To Include ZYESAMI In I-SPY COVID-19 Trial, EQS-News: Relief and NeuroRx Conclude Enrollment in their Phase 2b/3 Trial of RLF-100(TM) for Critical COVID-19 with Respiratory Failure, Relief Appoints Chris L.J.J.